Cubist Systematic Strategies’s Centessa Pharmaceuticals CNTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
+276,452
| New | +$3.63M | 0.02% | 570 |
|
|
2025
Q1 | – | Sell |
-45,885
| Closed | -$769K | – | 1590 |
|
|
2024
Q4 | $769K | Sell |
45,885
-88,235
| -66% | -$1.48M | ﹤0.01% | 877 |
|
|
2024
Q3 | $2.14M | Buy |
134,120
+108,047
| +414% | +$1.73M | 0.01% | 622 |
|
|
2024
Q2 | $235K | Sell |
26,073
-46,536
| -64% | -$420K | ﹤0.01% | 1059 |
|
|
2024
Q1 | $820K | Buy |
72,609
+67,785
| +1,405% | +$766K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $38.4K | Buy |
+4,824
| New | +$38.4K | ﹤0.01% | 1887 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$4K | – | 3314 |
|
|
2022
Q3 | $4K | Buy |
1,000
+432
| +76% | +$1.73K | ﹤0.01% | 3524 |
|
|
2022
Q2 | $3K | Buy |
+568
| New | +$3K | ﹤0.01% | 3767 |
|
|
2022
Q1 | – | Sell |
-632
| Closed | -$7K | – | 3559 |
|
|
2021
Q4 | $7K | Buy |
632
+432
| +216% | +$4.79K | ﹤0.01% | 3401 |
|
|
2021
Q3 | $3K | Sell |
200
-200
| -50% | -$3K | ﹤0.01% | 2920 |
|
|
2021
Q2 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 2866 |
|